Post hoc analysis—CST at 8, 24 and 40 weeks
| Ozurdex+laser N=40 | Number missing | Laser N=40 | Number missing | Significance* | |
|---|---|---|---|---|---|
| CST at baseline, median (IQR) | 459 (373 to 533) | 0 | 452 (407.5 to 559) | 0 | – |
| CST at 8 weeks, median (IQR) | 344.5 (302.5 to 402) | 0 | 443 (398 to 527) | 3 | <0.001 |
| CST at 24 weeks, median (IQR) | 326.5 (287 to 387) | 4 | 457 (363 to 565) | 5 | <0.001 |
| CST at 40 weeks, median (IQR) | 314 (287 to 387) | 8 | 421 (360.5 to 573) | 8 | <0.001 |
| CST at 56 weeks, median (IQR) | 301.5 (281 to 379) | 2 | 381 (339 to 544) | 1 | <0.001 |
*Significance of change in CST from baseline using natural log-transformation and analysis of covariance.
CST, central subfield thickness; n, number of patients/eyes; N, total number of patients/eyes.